Medicines List

Description

Co-Enalapril-Tchaikapharma contains a combination of enalapril and hydrochlorothiazide. Enalapril is angiotensin converting enzyme (ACE) inhibitor, which lowers blood pressure by widening blood vessels. Hydrochlorothiazide is a thiazide diuretic, which lowers blood pressure by excreting more water and salts by the kidneys.

Indications

Co-Enalapril-Tchaikapharma is indicated for the treatment of:
– essential hypertension that cannot be treated with angiotensin converting enzyme inhibitor monotherapy.

Subject to medical prescription.

Concentrations and pharmaceutical form: 20 mg/12.5 mg tablets

Description

Cefotaxime-Tchaikapharma belongs to a group of antibiotics, called cephalosporins. They works by killing the bacteria that cause infections.

Indications

Cefotaxime-Tchaikapharma for injections is used for in a wide range of serious (severe) bacterial infections, including:
– blood infections (septicaemia);
– bones (osteomyelitis);
– heart valves (endocarditis);
– membranes covering the cerebral cortex (meningitis);
– abdominal lining (peritonitis);
– preventing or treating infections after surgery.

Subject to medical prescription.

Concentration and pharmaceutical form: 1 g powder for solution for injection

Description

Cordacare contains an active substance lisinopril and belongs to a group of medicines called ACE inhibitors (angiotensin converting enzyme inhibitors). Inhibition of ACE leads to decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion.

Indications

Cordacare is indicated for:
– treatment of arterial hypertension;
– treatment of heart failure;
– treatment of haemodynamically stable patients within 24 hours after an acute myocardial infarction as a precaution against left ventricular dysfunction;
– treatment of renal disease in hypertensive patients with type 2 diabetes mellitus and incipient nephropathy.

Subject to medical prescription.

Concentration and pharmaceutical form: 10 mg, 20 mg tablets

Description

Pentoxifylline-Tchaikapharma is a peripheral vasodilator with a favorable hemorheological effect, mainly as a result of decreased blood and plasma viscosity, inhibition of platelet aggregation and increased erythrocyte deformability.

Indications

Pentoxifylline-Tchaikapharma is indicated for:
– disorders of the peripheral arterial macro- and microcirculation due to atherosclerosis, diabetes and vascular spasms (claudicatio intermittens, diabetic macro- and microangiopathy, Reynaud’s syndrome, ulcus cruris, gangrene);
– disorders of the peripheral venous circulation;
– in cerebrovascular disease (transient ischemic crises, consequences of chronic cerebrovascular insufficiency), acute and chronic conditions due to insufficient blood supply to the retina, rarely in angioneuropathy.

Subject to medical prescription.

Concentration and pharmaceutical form: 400 mg prolonged release tablets